Ad Scientiam
Paris
About Ad Scientiam
Ad Scientiam develops innovative digital solutions for patient monitoring in real life. Building on the growing possibilities offered by smartphones, Ad Scientiam creates new clinically-validated medical standards, in a collaborative ecosystem of patients, doctors and researchers. MSCopilot® is Ad Scientiam’s first solution CE marked as a Class 1 medical device, dedicated to the monitoring of patients with multiple sclerosis. Ad Scientiam works on several other solutions in Alzheimer’s Disease, Parkinson's Disease, Rheumatoid Arthritis, etc. Ad Scientiam employs 25 people at its two sites in France (the Pitié-Salpêtrière hospital and Station F campus) and in the United States (Seattle).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $8.1M
- Last round: Series Unknown (Nov 2025)
- Website: adscientiam.com
- Phone: +33 1 57 27 41 94
Industries & Categories
Clinical Trials, Health Care, Information Technology, IT Management, Medical
Social Profiles
Canonical: https://fsome.com/organization/ad-scientiam-93888 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.